
0:00
28:32
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.
Advertising Inquiries: https://redcircle.com/brands
Więcej odcinków z kanału "Run the List"



Nie przegap odcinka z kanału “Run the List”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








